1
and might require specific prevention strategies (eg, modifying the use of antithrombotic drugs) or, in the future, disease-modifying treatments targeting vascular β-amyloid.
2 MRI with blood-sensitive sequences can detect haemorrhagic small vessel disease biomarkers, including cerebral microbleeds and cortical superficial siderosis, 3 making it the best in-vivo diagnostic modality for CAA. By contrast, although widely available as the first diagnostic test for acute intracerebral haemorrhage, the value of CT for diagnosing CAA is uncertain.
In The Lancet Neurology, Mark A Rodrigues and colleagues did a diagnostic accuracy study 4 of acute non-contrast CT brain scans in a prospective populationbased inception cohort study of adults with first-ever intracerebral haemorrhage who died and underwent research autopsy. Of the 62 participants with lobar intracerebral haemorrhage, 36 (58%) were associated with moderate or severe CAA compared with 26 (42%) that were associated with absent or mild CAA, and were independently associated with subarachnoid blood extension (32 [89%] of 36; p=0·014), finger-like projections associated with the haematoma (14 [39%] of 36; p=0·043), and APOE ε4 possession (18 [50%] of 36; p=0·0020). The diagnostic criteria for CAA-associated lobar intracerebral haemorrhage had excellent discrimination (c statistic 0·92, 95% CI 0·86-0·98), confirmed by internal validation. For the rule-out criteria, neither subarachnoid haemorrhage nor APOE ε4 possession had 100% sensitivity (95% CI 88-100), whereas for the rule-in criteria, subarachnoid haemorrhage and either APOE ε4 possession or finger-like projections had 96% specificity (95% CI 78-100). A simplified CT-only model found subarachnoid haemorrhage alone had 89% sensitivity (95% CI 73-96), whereas subarachnoid haemorrhage and finger-like projections had 100% specificity (95% CI 84-100).
The study was of high methodological quality, including population-based recruitment, blinded assessment of the index diagnostic test, and clear presentation of diagnostic accuracy and statistical uncertainty. Autopsy with standardised neuropathological evaluation is the best available reference standard to decide whether CAA is likely to have caused a particular intracerebral haemorrhage, although, as the authors note, other non-CAA small vessel disease (eg, arterioloscerosis or lipohyalinosis) frequently co-existed with CAA and so might have also contributed to some lobar intracerebral haemorrhage.
The Edinburgh criteria could open a new chapter in CAA diagnosis because CT scanning is well tolerated by almost all acute patients with intracerebral haemorrhage and is more widely available than MRI, especially in countries with poor brain imaging resources. If CAA could be accurately diagnosed on the basis of acute CT findings, this diagnosis would rapidly provide clinicians, patients, and families with important information on prognosis in the acute stage of intracerebral haemorrhage that otherwise might be available only later or not at all.
However, substantial limitations need to be addressed before the Edinburgh criteria might be useful for routine clinical practice. Most importantly, external validation must ensure that the excellent model performance does not relate to specific circumstances of patient population, recruitment, CT scan rating, or analysis. The included population was biased towards older patients with more severe intracerebral haemorrhage, early death, and other adverse prognostic features, so might not be applicable to patients with mild intracerebral haemorrhage in whom long-term management plans are needed. Furthermore, progressive cognitive impairment and transient focal neurological episodes are increasingly recognised as presenting syndromes of CAA, 5 which were not included in this study. An important next step is to compare the Edinburgh CT-based criteria to the established and widely used MRI-based Boston diagnostic criteria, which, using strictly lobar bleeding and cortical superficial siderosis, have excellent sensitivity and good specificity for CAA, 6 ideally using a brain tissue diagnosis as a common reference standard. Unfortunately, the authors could only obtain MRI in seven patients, so could not investigate this. Future studies should also determine whether CT-defined
